Skip to the page

Data / Drug companies / Diltiazem hydrochloride

Diltiazem hydrochloride: 55 companies and 289 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Diltiazem hydrochloride is listed in the FDA National Drug Code Directory by 55 companies, with 289 products in commercial distribution. 253 of the products (87.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, extended release; tablet; tablet, extended release, and the newest product started marketing on October 1, 2026.

The request: Get every company that lists diltiazem hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
55
Products
289
Generic (ANDA) products
253 (87.5%)
Application numbers
40
Routes
Oral, Intravenous
Brand names
Tiadylt Er, Tiazac Extended Release, Cartia XT, Cardizem La, Matzim La, Cardizem CD, Cardizem, Cartia XT
openFDA record search
api.fda.gov

Companies that list diltiazem hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Bryant Ranch Prepack25capsule, extended release; capsule, coated, extended releaseGeneric drugs (ANDA)September 26, 2022
Bausch Health US LLC20capsule, extended release; tablet, extended releaseNew drug applications (NDA)August 20, 2014
Zydus Lifesciences Limited15capsule, extended release; tabletGeneric drugs (ANDA)May 25, 2026
Oceanside Pharmaceuticals14capsule, extended release; tabletAuthorized generics (NDA)August 20, 2014
Alembic Pharmaceuticals Inc.12capsule, extended release; tablet, film coatedGeneric drugs (ANDA)November 14, 2025
Alembic Pharmaceuticals Limited12capsule, extended release; tablet, film coatedGeneric drugs (ANDA)November 14, 2025
Zydus Pharmaceuticals USA Inc.11capsule, extended releaseGeneric drugs (ANDA)November 8, 2017
ScieGen Pharmaceuticals, Inc.10tablet, extended release; tabletGeneric drugs (ANDA)April 6, 2023
Sun Pharmaceutical Industries, Inc.10capsule, extended releaseGeneric drugs (ANDA)October 31, 2011
Slate Run Pharmaceuticals, LLC9tablet, extended release; capsule, extended releaseGeneric drugs (ANDA)March 20, 2023
Ingenus Pharmaceuticals, LLC8capsule, extended releaseGeneric drugs (ANDA)July 3, 2025
Upsher-Smith Laboratories, LLC8capsule, extended releaseGeneric drugs (ANDA)May 1, 2023
A-S Medication Solutions7capsule, extended release; tabletGeneric drugs (ANDA)September 26, 2022
American Health Packaging6capsule, coated, extended release; tablet, film coatedGeneric drugs (ANDA)December 8, 2023
Bryant Ranch Prepack6capsule, coated, extended release; capsule, extended releaseGeneric drugs (ANDA)October 1, 2015
Cipla USA Inc.6tablet, extended releaseGeneric drugs (ANDA)June 12, 2023
Hikma Pharmaceuticals USA Inc.6injectionGeneric drugs (ANDA)December 17, 2008
Actavis Pharma, Inc.5tablet, extended releaseGeneric drugs (ANDA)March 28, 2011
Golden State Medical Supply, Inc.5capsule, extended releaseGeneric drugs (ANDA)June 14, 2019
Macleods Pharmaceuticals Limited5capsule, extended releaseGeneric drugs (ANDA)June 23, 2023
NCS HealthCare of Ky, LLC DBA Vangard Labs5capsule, extended release; tablet, film coatedGeneric drugs (ANDA)June 14, 2019
Actavis Pharma, Inc.4capsule, extended releaseGeneric drugs (ANDA)July 9, 1998
Chartwell RX, LLC4tabletGeneric drugs (ANDA)November 5, 1992
Golden State Medical Supply, Inc.4capsule, extended releaseGeneric drugs (ANDA)August 30, 2018
Major Pharmaceuticals4capsule, extended releaseGeneric drugs (ANDA)August 9, 2022
Teva Pharmaceuticals USA, Inc.4tablet, film coatedGeneric drugs (ANDA)December 26, 1995
Viona Pharmaceuticals Inc4tabletGeneric drugs (ANDA)May 25, 2026
Accord Healthcare Inc.3capsule, extended releaseGeneric drugs (ANDA)September 11, 2020
Apotex Corp.3capsule, extended releaseGeneric drugs (ANDA)July 30, 2001
AvKARE3capsule, extended releaseGeneric drugs (ANDA)April 3, 2025
Cardinal Health 107, LLC3capsule, extended releaseGeneric drugs (ANDA)August 1, 2023
Coupler LLC3tablet; capsule, extended releaseGeneric drugs (ANDA)May 1, 2025
Cranbury Pharmaceuticals, LLC3capsule, extended releaseGeneric drugs (ANDA)October 1, 2026
Dr. Reddy's Laboratories Inc.3capsule, extended releaseGeneric drugs (ANDA)September 10, 2024
Eugia US LLC3injection, solutionGeneric drugs (ANDA)March 29, 2023
Glenmark Pharmaceuticals Inc., USA3capsule, extended releaseGeneric drugs (ANDA)March 22, 2021
Mylan Institutional Inc.3capsule, extended releaseGeneric drugs (ANDA)December 15, 1999
Mylan Pharmaceuticals Inc.3capsule, extended releaseGeneric drugs (ANDA)May 2, 1997
NorthStar Rx LLC3capsule, extended releaseGeneric drugs (ANDA)February 22, 2022
NuCare Pharmaceuticals,Inc.3capsule, extended release; tabletGeneric drugs (ANDA)December 25, 2010
Safecor Health, LLC3capsule, extended releaseGeneric drugs (ANDA)February 2, 2026
Medical Purchasing Solutions, LLC2injection; injection, solutionGeneric drugs (ANDA)June 1, 2024
Northwind Health Company, LLC2tabletGeneric drugs (ANDA)January 18, 2024
Remedyrepack Inc.2capsule, extended releaseGeneric drugs (ANDA)August 19, 2022
WG Critical Care, LLC2injection, solutionNew drug applications (NDA)March 21, 2025
Actavis Pharma, Inc.1capsule, extended releaseGeneric drugs (ANDA)November 25, 2013
Direct_Rx1capsule, extended releaseGeneric drugs (ANDA)April 6, 2022
HF Acquisition Co LLC, DBA HealthFirst1injection, solutionGeneric drugs (ANDA)June 1, 2024
Hospira, Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 30, 2005
Northwind Health Company, LLC1tablet, film coatedGeneric drugs (ANDA)August 11, 2022
Preferred Pharmaceuticals Inc.1capsule, extended releaseGeneric drugs (ANDA)February 15, 2021
ProPharma Distribution1injection, solutionGeneric drugs (ANDA)June 1, 2024
Proficient Rx LP1tablet, film coatedGeneric drugs (ANDA)December 26, 1995
Sagent Pharmaceuticals1injection, solutionGeneric drugs (ANDA)June 1, 2024
Sun Pharmaceutical Industries, Inc.1capsule, extended releaseGeneric drugs (ANDA)October 31, 2018

Dosage forms

Dosage formProductsShare
Capsule, extended release17359.9%
Tablet2910%
Tablet, extended release2910%
Tablet, film coated206.9%
Capsule, coated, extended release186.2%
Injection, solution93.1%
Injection72.4%
Tablet, coated31%
Injection, powder, lyophilized, for solution10.3%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)25387.5%
New drug applications (NDA)227.6%
Authorized generics (NDA)144.8%

Pharmacologic classes

ClassProducts
Calcium Channel Blocker289

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.